Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Respiratory tract sensory C-fibers are unmyelinated, slow-conducting vagal afferent nerves that serve as primary sensors for noxious stimuli in the airways [1]. These fibers are characterized by their sensitivity to capsaicin, which activates the Transient Receptor Potential Vanilloid 1 (TRPV1) channels expressed on their terminals [2]. When stimulated by chemical irritants, inflammatory mediators (e.g., bradykinin, prostaglandins), or mechanical stress, these nerves trigger protective reflexes such as cough and bronchoconstriction [3]. Furthermore, they release sensory neuropeptides like Substance P and Calcitonin Gene-Related Peptide (CGRP), which mediate neurogenic inflammation, including vasodilation and edema [4]. In pathological conditions like chronic refractory cough or asthma, these fibers often exhibit hypersensitivity, leading to exaggerated responses to innocuous stimuli [5]. Pharmacological targeting of these nerves involves either desensitizing the fibers using capsaicinoids or inhibiting specific ion channels like TRPV1, TRPA1, and P2X3 to reduce neuronal excitability and alleviate symptoms [6]. Clinical trials for chronic cough have successfully targeted the P2X3 receptor on these fibers, demonstrating significant reductions in cough frequency [5]. However, modulating these nerves carries risks such as the suppression of the protective cough reflex and potential side effects like taste disturbance or thermal dysregulation depending on the specific receptor targeted [6].
Antagonism of P2X3, TRPV1, or TRPA1 receptors to inhibit neuronal firing; Desensitization of nerve terminals via TRPV1 agonists.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory tract sensory C-fiber (C-fiber) (C-fiber).